Literature DB >> 30072557

The reversal of anticoagulation in clinical practice .

Sally Thomas1,2, Michael Makris3,2.   

Abstract

Widespread use of anticoagulant drugs for treatment and -prevention of thromboembolic events means it is common to encounter patients requiring reversal of anticoagulation for management of bleeding or invasive procedures. While supportive and general measures apply for patients on all agents, recent diversification in the number of licensed agents makes an understanding of drug-specific reversal strategies essential. Recognising effects upon, and limitations of, laboratory measures of coagulation also plays an important role. An understanding of reversal strategies alone is insufficient to competently care for patients who may require anticoagulation reversal. It is also necessary to reduce the need for reversal through correct prescribing and by employing appropriate periprocedural bridging strategies for elective and semi-elective procedures. Finally, consideration of whether and when to reintroduce an anticoagulant drug following reversal is important not only to balance bleeding and thrombotic risks for individual patients but also for timely management of discharge. © Royal College of Physicians 2018. All rights reserved.

Entities:  

Keywords:  anticoagulants; direct acting oral anticoagulants; haemorrhage; reversal; surgery

Mesh:

Substances:

Year:  2018        PMID: 30072557      PMCID: PMC6334060          DOI: 10.7861/clinmedicine.18-4-314

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  30 in total

1.  A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.

Authors:  H G Watson; T Baglin; S L Laidlaw; M Makris; F E Preston
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

Review 2.  Guidelines on oral anticoagulation with warfarin - fourth edition.

Authors:  David Keeling; Trevor Baglin; Campbell Tait; Henry Watson; David Perry; Caroline Baglin; Steve Kitchen; Michael Makris
Journal:  Br J Haematol       Date:  2011-06-14       Impact factor: 6.998

3.  A practical guideline for the haematological management of major haemorrhage.

Authors:  Beverley J Hunt; Shubha Allard; David Keeling; Derek Norfolk; Simon J Stanworth; Kate Pendry
Journal:  Br J Haematol       Date:  2015-07-06       Impact factor: 6.998

4.  Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.

Authors:  Steve Kitchen; Elaine Gray; Ian Mackie; Trevor Baglin; Mike Makris
Journal:  Br J Haematol       Date:  2014-06-14       Impact factor: 6.998

5.  Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study.

Authors:  Ammar Majeed; Anna Ågren; Margareta Holmström; Maria Bruzelius; Roza Chaireti; Jacob Odeberg; Eva-Lotta Hempel; Maria Magnusson; Tony Frisk; Sam Schulman
Journal:  Blood       Date:  2017-08-23       Impact factor: 22.113

6.  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.

Authors:  Genmin Lu; Francis R DeGuzman; Stanley J Hollenbach; Mark J Karbarz; Keith Abe; Gail Lee; Peng Luan; Athiwat Hutchaleelaha; Mayuko Inagaki; Pamela B Conley; David R Phillips; Uma Sinha
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

Review 7.  Measurement and reversal of the direct oral anticoagulants.

Authors:  Bethany T Samuelson; Adam Cuker
Journal:  Blood Rev       Date:  2016-09-02       Impact factor: 8.250

8.  A specific antidote for dabigatran: functional and structural characterization.

Authors:  Felix Schiele; Joanne van Ryn; Keith Canada; Corey Newsome; Eliud Sepulveda; John Park; Herbert Nar; Tobias Litzenburger
Journal:  Blood       Date:  2013-03-08       Impact factor: 22.113

9.  Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Authors:  Ravi Sarode; Truman J Milling; Majed A Refaai; Antoinette Mangione; Astrid Schneider; Billie L Durn; Joshua N Goldstein
Journal:  Circulation       Date:  2013-08-09       Impact factor: 29.690

Review 10.  Laboratory measurement of the direct oral anticoagulants.

Authors:  Brian J Dale; Noel C Chan; John W Eikelboom
Journal:  Br J Haematol       Date:  2015-10-22       Impact factor: 6.998

View more
  6 in total

1.  The past, the present, and the future: reflecting on -medical history as we welcome new leaders.

Authors:  Ed Nicol
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

Review 2.  Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19.

Authors:  Zheng Cai; Mark I Greene; Zhiqiang Zhu; Hongtao Zhang
Journal:  Antibodies (Basel)       Date:  2020-10-10

3.  Interventional Algorithm in Gastrointestinal Bleeding-An Expert Consensus Multimodal Approach Based on a Multidisciplinary Team.

Authors:  Anabela Rodrigues; Alexandre Carrilho; Nuno Almeida; Cilénia Baldaia; Ângela Alves; Manuela Gomes; Luciana Gonçalves; António Robalo Nunes; Carla Leal Pereira; Mário Jorge Silva; José Aguiar; Rosário Orfão; Pedro Duarte; Rui Tato Marinho
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  Incidence Rates of Bleeding and Emergency Surgery Due to Trauma or Fracture Among Japanese Patients with Non-valvular Atrial Fibrillation Receiving Oral Anticoagulation Therapy.

Authors:  Masahiro Yasaka; Hiroyuki Yokota; Michiyasu Suzuki; Teiichi Yamane; Yasuhisa Ono
Journal:  Cardiol Ther       Date:  2020-05-11

Review 5.  Updated recommendations for the treatment of venous thromboembolism.

Authors:  Junshik Hong; Seo-Yeon Ahn; Yoo Jin Lee; Ji Hyun Lee; Jung Woo Han; Kyoung Ha Kim; Ho-Young Yhim; Seung-Hyun Nam; Hee-Jin Kim; Jaewoo Song; Sung-Hyun Kim; Soo-Mee Bang; Jin Seok Kim; Yeung-Chul Mun; Sung Hwa Bae; Hyun Kyung Kim; Seongsoo Jang; Rojin Park; Hyoung Soo Choi; Inho Kim; Doyeun Oh
Journal:  Blood Res       Date:  2021-03-31

Review 6.  An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants.

Authors:  Mark Terence P Mujer; Manoj P Rai; Varunsiri Atti; Ian Limuel Dimaandal; Abigail S Chan; Shiva Shrotriya; Krishna Gundabolu; Prajwal Dhakal
Journal:  Adv Hematol       Date:  2020-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.